Skip to main content
Premium Trial:

Request an Annual Quote

PredictImmune, Crohn's & Colitis Foundation Collaborate on IBD Test Validation Study

NEW YORK – Immune disease prognostic firm PredictImmune announced on Thursday a collaboration with the Crohn's & Colitis Foundation to validate the company's PredictSure IBD test in a diverse patient population.

The Predicting Crohn's and Colitis Outcomes in the United States (PRECIOUS) study will track up to 200 patients from 15 medical centers across the US with Crohn's disease or ulcerative colitis who aren't receiving systemic steroids, immunomodulators, or biologics. The first patients, who will be monitored for up to a year, have been recruited by New York University/Bellevue hospital, the company said.

Patients will be sorted into high-risk and low-risk cohorts using the PredictSure IBD test, which stratifies patients based on the risk of experiencing a severe disease course requiring multiple escalations in treatment.

"Personalized therapy is key to optimizing outcomes and minimizing risks for our patients with IBD," Lea Ann Chen, the study's principal investigator, said in a statement. "It is also dependent on having accurate predictors of disease behavior."

PredictImmune and the foundation are jointly funding the study.

Cambridge, UK-based PredictImmune announced last month its partnership with KSL Biomedical to promote and provide the PredictSure IBD test in North America.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.